Fingerprint
Dive into the research topics of 'Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Pemigatinib for previously treated, locally advanced or metastatic cholangiocarcinoma: a multicentre, open-label, phase 2 study
Ghassan K. Abou-Alfa, Vaibhav Sahai, Antoine Hollebecque, Gina Vaccaro, Davide Melisi, Raed Al-Rajabi, Andrew S. Paulson, Mitesh J. Borad, David Gallinson, Adrian G. Murphy, Do Youn Oh, Efrat Dotan, Daniel V. Catenacci, Eric Van Cutsem, Tao Ji, Christine F. Lihou, Huiling Zhen, Luis Féliz, Arndt Vogel
Research output: Contribution to journal › Article › peer-review
161
Scopus
citations